{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:24:27Z","timestamp":1773854667831,"version":"3.50.1"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.582102","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T05:56:40Z","timestamp":1603432600000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19"],"prefix":"10.3389","volume":"11","author":[{"given":"Howard M.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred S.","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chulbul M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(20)30004-5","article-title":"Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study","author":"Chu","year":"2020","journal-title":"Lancet Microbe"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e2106","DOI":"10.1002\/rmv.2106","article-title":"Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures","volume":"30","author":"Yan","year":"2020","journal-title":"Rev Med Virol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.0757","article-title":"Coronavirus Infections-More Than Just the Common Cold","volume":"323","author":"Paules","year":"2020","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.30.20047993","article-title":"Assessing the interactions between COVID-19 and influenza in the United States","author":"Zipfel","year":"2020","journal-title":"medRxiv"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2002387","article-title":"Covid-19 - Navigating the Uncharted","volume":"382","author":"Fauci","year":"2020","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00183","article-title":"SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function","volume":"6","author":"Ahmed","year":"2015","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01857-10","article-title":"Viral exploitation of host SOCS protein functions","volume":"85","author":"Akhtar","year":"2011","journal-title":"J Virol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)80048-3","article-title":"SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality","volume":"98","author":"Marine","year":"1999","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.161271798","article-title":"Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3","volume":"98","author":"Roberts","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2010.10.018","article-title":"The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis","volume":"232","author":"Jager","year":"2011","journal-title":"J Neuroimmunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201343370","article-title":"Therapeutical potential of a peptide mimicking the SOCS1 kinase inhibitory region in skin immune responses","volume":"43","author":"Madonna","year":"2013","journal-title":"Eur J Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016020237","article-title":"Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy","volume":"28","author":"Recio","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002006","article-title":"Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes\/macrophages in hepatitis C virus infection","volume":"186","author":"Zhang","year":"2011","journal-title":"J Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.12.006","article-title":"Regulatory T Cells Control Antigen-Specific Expansion of Tfh Cell Number and Humoral Immune Responses via the Coreceptor CTLA-4","volume":"41","author":"Wing","year":"2014","journal-title":"Immunity"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.12.005","article-title":"The coinhibitory receptor ctla-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells","volume":"41","author":"Sage","year":"2014","journal-title":"Immunity"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302369","article-title":"Nivolumab plus ipilimumab in advanced melanoma","volume":"369","author":"Wolchok","year":"2013","journal-title":"N Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003819","article-title":"Inhibition of SOCS1-\/- lethal autoinflammatory disease correlated to enhanced peripheral Foxp3+ regulatory T cell homeostasis","volume":"187","author":"Collins","year":"2011","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental Mechanisms of Immune Checkpoint Blockade Therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12708","article-title":"Combination therapy strategies for improving PD-1 blockade efficacy: a new era in cancer immunotherapy","volume":"283","author":"Chowdhury","year":"2018","journal-title":"J Intern Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.00728-18","article-title":"The Coronavirus Transmissible Gastroenteritis Virus Evades the Type I Interferon Response through IRE1\u03b1-Mediated Manipulation of the MicroRNA miR-30a-5p\/SOCS1\/3 Axis","volume":"92","author":"Ma","year":"2018","journal-title":"J Virol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"17485","DOI":"10.1038\/s41598-017-17730-2","article-title":"Constitutively elevated levels of SOCS1 suppress innate responses in DF-1 immortalised chicken fibroblast cells","volume":"7","author":"Giotis","year":"2017","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.8.5058","article-title":"Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist","volume":"178","author":"Waiboci","year":"2007","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900570","article-title":"HSV-1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasion","volume":"183","author":"Frey","year":"2009","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902895","article-title":"Enhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signaling","volume":"185","author":"Ahmed","year":"2010","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00574","article-title":"A SOCS1\/3 Antagonist Peptide Protects Mice Against Lethal Infection with Influenza A Virus","volume":"6","author":"Ahmed","year":"2015","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-virology-092917-043339","article-title":"Host Determinants of Influenza RNA Synthesis","volume":"6","author":"Peacock","year":"2019","journal-title":"Annu Rev Virol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1089\/vim.2014.0136","article-title":"Upregulation of the Suppressors of Cytokine Signaling 1 and 3 Is Associated with Arrest of Phosphorylated-STAT1 Nuclear Importation and Reduced Innate Response in Denguevirus-Infected Macrophages","volume":"29","author":"Estrada-Jim\u00e9nez","year":"2016","journal-title":"Viral Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9030163","article-title":"Zika Virus-Induction of the Suppressor of Cytokine Signaling 1\/3 Contributes to the Modulation of Viral Replication","volume":"9","author":"Seong","year":"2020","journal-title":"Pathogens"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2009.0259","article-title":"Transcriptional upregulation of SOCS 1 and suppressors of cytokine signaling 3 mRNA in the absence of suppressors of cytokine signaling 2 mRNA after infection with West Nile virus or tick-borne encephalitis virus","volume":"10","author":"Mansfield","year":"2010","journal-title":"Vector Borne Zoonotic Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1128\/JVI.01462-09","article-title":"Interaction between Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1","volume":"84","author":"Okumura","year":"2010","journal-title":"J Virol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.270207","article-title":"Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2","volume":"286","author":"Piganis","year":"2011","journal-title":"J Biol Chem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2010.06.014","article-title":"SARS spike protein induces phenotypic conversion of human B cells to macrophage-like cells","volume":"47","author":"Chiang","year":"2010","journal-title":"Mol Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20556","article-title":"Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections","volume":"78","author":"Okabayashi","year":"2006","journal-title":"J Med Virol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0327-4","article-title":"COVID-19: towards understanding of pathogenesis","volume":"30","author":"Cao","year":"2020","journal-title":"Cell Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6548","article-title":"COVID-19 and African Americans","volume":"323","author":"Yancy","year":"2020","journal-title":"JAMA"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30244-7","article-title":"Increased cardiovascular mortality in African Americans with COVID-19","volume":"8","author":"McGonagle","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-020-0597-4","article-title":"COVID-19 and the role of chronic inflammation in patients with obesity","volume":"44","author":"Chiappetta","year":"2020","journal-title":"Int J Obes (Lond)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0682","article-title":"Obesity Is a Risk Factor for Greater COVID-19 Severity","volume":"43","author":"Gao","year":"2020","journal-title":"Diabetes Care"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2020.100283","article-title":"Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients","volume":"19","author":"Al-Benna","year":"2020","journal-title":"Obes Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1748-1716.2007.01782.x","article-title":"SOCS proteins causing trouble in insulin action","volume":"192","author":"Lebrun","year":"2008","journal-title":"Acta Physiol (Oxf)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2011.208","article-title":"Obesity is associated with impaired immune response to influenza vaccination in humans","volume":"36","author":"Sheridan","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2019.1622419","article-title":"Challenges in estimating influenza vaccine effectiveness","volume":"18","author":"Ainslie","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0448-7","article-title":"Autoimmune and inflammatory diseases following COVID-19","volume":"16","author":"Galeotti","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/iub.2380","article-title":"SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities","author":"Delcuve","year":"2020","journal-title":"IUBMB Life"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/iub.2379","article-title":"SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics","author":"Beacon","year":"2020","journal-title":"IUBMB Life"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01131","article-title":"Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation","volume":"11","author":"Cardone","year":"2020","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur J Intern Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1473-3099(20)30651-4","article-title":"COVID-19 and multisystem inflammatory syndrome in children and adolescents","author":"Jiang","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2020.07.033","article-title":"Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1","author":"Lee","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41591-020-1054-6","article-title":"Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection","author":"Carter","year":"2020","journal-title":"Nat Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/13993003.02182-2020","article-title":"Potential of regulatory T-cell-based therapies in the management of severe COVID-19","volume":"56","author":"Stephen-Victor","year":"2020","journal-title":"Eur Respir J"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01367-z","article-title":"Pharmaco-Immunomodulatory Therapy in COVID-19","volume":"80","author":"Rizk","year":"2020","journal-title":"Drugs"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0312-7","article-title":"COVID-19: risk for cytokine targeting in chronic inflammatory diseases","volume":"20","author":"Schett","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.140289","article-title":"Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis","volume":"5","author":"Wilson","year":"2020","journal-title":"JCI Insight"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100016","article-title":"Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients","volume":"1","author":"Bonam","year":"2020","journal-title":"Cell Rep Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2472555220958385","DOI":"10.1177\/2472555220958385","article-title":"A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19","author":"Maciorowski","year":"2020","journal-title":"SLAS Discov"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1055\/a-1170-4395","article-title":"Interferons in the Therapy of Severe Coronavirus Infections: A Critical Analysis and Recollection of a Forgotten Therapeutic Regimen with Interferon Beta","volume":"70","author":"Brzoska","year":"2020","journal-title":"Drug Res (Stuttg)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104811","article-title":"Antiviral activities of type I interferons to SARS-CoV-2 infection","volume":"179","author":"Mantlo","year":"2020","journal-title":"Antiviral Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e1008737","DOI":"10.1371\/journal.ppat.1008737","article-title":"Interplay between SARS-CoV-2 and the type I interferon response","volume":"16","author":"Sa Ribero","year":"2020","journal-title":"PLoS Pathog"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-64782\/v1","article-title":"JAK-Inhibitor and Type I Interferon Ability to Produce Favorable Clinical Outcomes in COVID-19 Patients: A Systematic Review and Meta-Analysis","author":"Walz","year":"2020","journal-title":"Res Sq"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108185","article-title":"SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant","volume":"32","author":"Konno","year":"2020","journal-title":"Cell Rep"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0891-0","article-title":"The Janus kinase 1\/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation","volume":"34","author":"La Ros\u00e9e","year":"2020","journal-title":"Leukemia"},{"key":"B65","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cytogfr.2020.06.013","article-title":"The potential of JAK\/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19","volume":"54","author":"Goker Bagca","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102569","article-title":"Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review","volume":"19","author":"Alijotas-Reig","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e1003293","DOI":"10.1371\/journal.pmed.1003293","article-title":"Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)","volume":"17","author":"Juul","year":"2020","journal-title":"PLoS Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/L20-0681","article-title":"Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports","author":"Gladstone","year":"2020","journal-title":"Ann Intern Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.582102\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T05:56:42Z","timestamp":1603432602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.582102\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":68,"alternative-id":["10.3389\/fimmu.2020.582102"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.582102","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]},"article-number":"582102"}}